| |
|
|
Session 112
Poster Presentations The Effects of Antiretroviral Therapy during Pregnancy Thursday 1:30 - 3:30 pm Hall B |
| 886 | Pharmacokinetics and Safety of d4T and 3TC in HIV-infected Pregnant Women and Their Infants (PACTG 332) N. Wade*1, J. Unadkat2, S. Huang3, D. Shapiro3, S. Yasin4, A. Mathias2, R. Samelson5, Y. Bryson6, L. Mofenson7, H. Watts7, M. Smith8, S. Burchett9, PACTG 332 Team 1Children's Hosp at Albany Med Ctr, NY; 2Univ of Washington, Seattle; 3Harvard Sch of Public Hlth, Boston, MA; 4Univ of Miami, FL; 5Brigham and Women's Hosp, Boston, MA; 6Univ of California at Los Angeles; 7Nat Inst of Child Hlth and Human Dev, Rockville, MD; 8Natl Inst of Allergy and Infectious Diseases, Bethesda, MD; and 9Children's Hosp, Harvard Med Sch, Boston, MA |
| 887 | Clinical Response, Safety, and Tolerabiliy to Saquinavir-SCG with Low-dose Ritonavir Boosting in Combination with Zidovudine and Lamivudine in HIV-1 Infected Pregnant Women: Preliminary Results of PACTG 386 C. D. Zorrilla*1, R. Van Dyke2, A. Bardeguez3, J. Pitt4, E. Acosta5, M. Hughes6, S. Huang6, B. Heckman7, S. Ortiz-Pujols7, B. Smith8, H. Watts9, L. Mofenson9 1Univ of Puerto Rico Sch of Med, San Juan; 2Tulane Univ Med Sch, New Orleans, LA; 3Univ of Med and Dentistry of New Jersey, Newark; 4Columbia Univ Coll, New York, NY; 5Univ of Alabama at Birmingham; 6Harvard Sch of Public Hlth, Boston, MA; 7Pediatric AIDS Clin Trials Group Operations Office, Silver Spring, MD; 8Div of Acquired Immunodeficiency Syndrome, NIAID, Rockville, MD; and 9Ctr for Res for Mothers and Children, NICHD, Rockville, MD |
| 888 | Maternal Toxicity and Pregnancy Outcome According to Antiretroviral Therapy during Pregnancy: An Analysis of the PACTG 316 Study D. H. Watts*1, R. Balasubramanian2, R. Maupin3, I. Delke4, C. Cunningham5, A. Dorenbaum6, S. Fiore7, M-L. Newell7, J. F. Delfraissy8, RD Gelber2, L Mofenson1, M Culnane9, J Sullivan 10, the PACTG 316 Study Team11 1Natl Inst of Hlth, Bethesda, MD; 2Harvard Sch of Public Hlth, Boston, MA; 3Louisiana State Univ, New Orleans; 4Univ of Florida, Jacksonville; 5State Univ of New York-Upstate Med Univ, Syracuse; 6Chiron Corp, Emeryville, CA; 7Inst of Child Hlth, London, UK; 8Agence Natl de Res sur le SIDA, Paris, France, Paris, France Villejuif, France; 9CDC, Bangkok, Thailand; 10Univ of Massachusetts, Worcester; and 11Pediatric AIDS Clin Trials Group Operations Office, Silver Spring, MD |
| 889 | Clinical, Virologic, and Immunologic Changes after Delivery among Women Receiving Nucleoside Therapy during Pregnancy D. H. Watts*1, J. Lambert2, E. R. Stiehm3, D. R. Harris4, J. Bethel4, L. Mofenson1, B. Mathieson1, M. G. Fowler5, G. Nemo1, the PACTG 185 Study Team6 1Natl Inst of Hlth, NIH, Bethesda, MD; 2Glaxo-Wellcome, Middlesex, UK; 3Univ of California at Los Angeles; 4Westat, Rockville, MD; 5CDC, Atlanta, GA; and 6Pediatric AIDS Clin Trials Group, Silver Spring, MD |
| 890 | Immune Activation During Late Pregnancy and Postpartum as Measured by Elevated Serum H. M. Truong*1, M. S. Sim1, M. Dillon1, C. Uittenbogaart1, R. Dickover1, S. Plaeger2, Y. Bryson1 1Univ of California at Los Angeles and 2Natl Inst of Hlth, Bethesda, MD |
| 891 | PACTG 353: Combined Treatment with HAART (NFV/3TC/ZDV) Increases Thymic Output in HIV-infected Pregnant Women Y. Bryson*1, R. Dickover1, A. Stek2, M. Mirochnic3, J. Connor4, L. Mofensen5, H. Watts5, S. Huang6, M. Hughes6, B. Cunningham7, L. Purdue5, D. Wara8, Y. Asfaw5, E. Smith9, PACTG 353 Team 1Univ of California at Los Angeles; 2Univ of Southern California, Los Angeles; 3Boston Univ, MA; 4Univ of California at San Diego; 5Natl Inst of Hlth, Bethesda, MD; 6Statistical and Data Analysis Ctr, Harvard Sch of Publ Hlth, Boston, MA; 7Frontier Sci and Tech Res Fndn, Buffalo, NY; 8Univ of California at San Francisco; and 9Pediatric AIDS Clin Trials Group Operations Office, Rockville MD |